A detailed history of N Verses Capital, LLC transactions in Viatris Inc stock. As of the latest transaction made, N Verses Capital, LLC holds 7,400 shares of VTRS stock, worth $85,840. This represents 0.05% of its overall portfolio holdings.

Number of Shares
7,400
Previous 5,900 25.42%
Holding current value
$85,840
Previous $70.4 Million 11.66%
% of portfolio
0.05%
Previous 0.17%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$10.05 - $12.02 $15,075 - $18,030
1,500 Added 25.42%
7,400 $78.7 Million
Q1 2024

Apr 25, 2024

BUY
$11.27 - $13.53 $66,493 - $79,827
5,900 New
5,900 $70.4 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track N Verses Capital, LLC Portfolio

Follow N Verses Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of N Verses Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on N Verses Capital, LLC with notifications on news.